Ultragenyx Pharmaceutical Inc.

Director at ARCT

Sold, on record
$124M
Dollars the filings state
Form 4 sales
2
Latest Aug 11, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ARCTArcturus Therapeutics Holdings Inc.Director

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ARCTUnusual
    Dec 9, 2020 2020

    Sold 800,000 shares at $100.81 ($80.7M)

    Ultragenyx Pharmaceutical Inc., Director, 10% owner

    Sold 26.7% of holdings ($302M position)2.2M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ARCTUnusual
    Aug 11, 2021 +245 days

    Sold 800,000 shares at $54.54 ($43.6M)

    Ultragenyx Pharmaceutical Inc., Director

    Sold 36.4% of holdings ($120M position)1.4M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Ultragenyx Pharmaceutical Inc.
Source
Aug 11, 2021Aug 12, 2021ARCTDirectorForm 4 sale800,000$43.6M36.4%UnusualSEC
Dec 9, 2020Dec 10, 2020ARCTDirector, 10% ownerForm 4 sale800,000$80.7M26.7%UnusualSEC